Search News Articles:
|
March 3, 2010
- PAREXEL INTERNATIONAL TO PRESENT AT RAYMOND JAMES 31ST ANNUAL INSTITUTIONAL INVESTORS CONFERENCE PAREXEL International Corporation (NASDAQ: PRXL) announced today it will be presenting at the Raymond James 31st Annual Institutional Investors Conference in Orlando, Florida Read the Press Release |
 |
|
March 2, 2010
- PAREXEL EXPERTS TO PRESENT LEADING INSIGHTS REGARDING KEY INDUSTRY TOPICS AT 22ND ANNUAL DIA EUROMEETING Boston, MA, March 2, 2010 — Experts from PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, will address important industry issues at the Drug Information Association (DIA) 22nd Annual EuroMeeting, being held from March 8 – 10, 2010 in Monaco. A number of PAREXEL’s thought leaders will present on topics ranging from risk-based contracted services relationship models, managing the end of patent, and improving submission success to ensuring therapeutic equivalence and developing borderline medical devices. Presentations from PAREXEL’s subsidiary, Perceptive Informatics, a leading eClinical solutions provider, will address leveraging technology for Patient-Reported Outcomes (PROs) as well as the benefits and challenges of adaptive trials. Read the Press Release |
|
|
February 23, 2010
- PAREXEL OPENS NEW EARLY PHASE UNIT IN SOUTH AFRICA, EXPANDING CAPABILITIES TO SUPPORT CLIENTS IN ACCELERATING DEVELOPMENT PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced that it has expanded its capabilities through the opening of a new early phase unit in Port Elizabeth, South Africa. The Port Elizabeth unit has added more than 40 beds to PAREXEL's global early phase capacity of over 580 beds, which is among the largest capacities worldwide. In addition to providing the capability to conduct a variety of studies in healthy volunteers, the core focus of the Port Elizabeth unit is on early phase studies in patients, from First in Man to Proof of Concept studies. Read the Press Release |
|
|
February 11, 2010
- PAREXEL ENHANCES EARLY PHASE BIOMARKER CAPABILITIES THROUGH ALLIANCE WITH PROTEOME SCIENCES PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, and Proteome Sciences plc (LSE: PRM), a leading provider of protein biomarker discovery, validation, and assay development services, today announced the formation of an alliance focused on enhancing PAREXEL's biomarker capabilities for early phase clinical development. PAREXEL is using Proteome Sciences' PS Biomarker Services(TM) protein and peptide biomarker capabilities to support biopharmaceutical companies in making earlier assessments of new compounds in development. Read the Press Release |
|
|
January 27, 2010
- LEADING LYMPHOMA EXPERT JOINS PERCEPTIVE INFORMATICS TEAM OF MEDICAL IMAGING SCIENTIFIC ADVISORS
Perceptive Informatics, a leading eClinical solutions provider and a subsidiary of PAREXEL International Corporation (NASDAQ: PRXL), today announced that Bruce D. Cheson, M.D., Professor of Medicine, Head of Hematology and Director of Hematology Research at Georgetown University Hospital's Lombardi Comprehensive Cancer Center, has joined its Medical Imaging Scientific Advisor Team. Perceptive combines the expertise of its global medical imaging team with the specialized therapeutic area expertise of these advisors to help clients make better, more informed decisions regarding the best use of medical imaging and associated clinical data in their development programs. Read the Press Release |
|
|
January 25, 2010
- PAREXEL REPORTS SECOND QUARTER FISCAL YEAR 2010 FINANCIAL RESULTS Boston, MA, January 25, 2010 – PAREXEL International Corporation (NASDAQ: PRXL) today announced its financial results for the second quarter ended December 31, 2009. For the three months ended December 31, 2009, PAREXEL’s consolidated service revenue increased 3.2% to $284.7 million compared with $275.8 million in the prior year period. Excluding the positive impact of foreign exchange of $14.0 million dollars in the quarter, revenue decreased approximately 2% from the prior year. Download PDF Read the Press Release |
|
|
January 14, 2010
- PERCEPTIVE INFORMATICS IS SELECTED BY ALMIRALL TO PROVIDE eCLINICAL SOLUTIONS FOR CRITICAL RESPIRATORY PROGRAM
Perceptive Informatics, a leading eClinical solutions provider and subsidiary of PAREXEL International Corporation (NASDAQ: PRXL), announced today that it has been selected by Almirall, an international pharmaceutical company, to provide core solutions in its eClinical Suite for several clinical trials in the respiratory therapeutic area. Through this relationship, Perceptive is leveraging the core capabilities of its eClinical Suite to support Almirall in gaining greater visibility into its clinical trials and improving data access for faster decision-making. Read the Press Release |
|
|
January 11, 2010
- PAREXEL ISSUES UPDATED FINANCIAL AND OPERATIONAL INFORMATION PAREXEL International Corporation (NASDAQ: PRXL) today raised its financial guidance expectations for the second quarter of Fiscal Year 2010 ended December 31, 2009, and for the full Fiscal Year 2010 ending June 30, 2010 Read the Press Release |
|
|
January 7, 2010
- PAREXEL INTERNATIONAL TO PRESENT AT THE 28TH ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE PAREXEL International Corporation (NASDAQ: PRXL) announced today it will be presenting at the 28th Annual J.P. Morgan Healthcare Conference in San Francisco, California. Read the Press Release |
|
|
January 6, 2010
- PAREXEL ANNOUNCES DATE OF SECOND QUARTER FISCAL YEAR 2010 EARNINGS RELEASE AND CONFERENCE CALL PAREXEL International Corporation (NASDAQ: PRXL) will release Second Quarter Fiscal Year 2010 financial results on Monday, January 25, 2010 after the close of the stock market. The announcement will be available on PAREXEL's website at www.parexel.com and on the PR Newswire website at www.prnewswire.com. Read the Press Release |
|
News Feed